Transcranial magnetic stimulation as a promising method of treatment in depression and various neuropsychiatric conditions. A literature review
DOI:
https://doi.org/10.12775/JEHS.2023.39.01.010Keywords
transcranial magnetic stimulation, tms, depression, treatment-resistant depressionAbstract
Background: Transcranial magnetic stimulation (TMS) is a method of non-invasive and painless brain stimulation with an electromagnetic field, which induces changes in the electric field in the brain leading to the cortical activity modulation and stimulation of neurons. Currently, transcranial magnetic stimulation is increasingly used in the diagnosis and treatment of various neuropsychiatric conditions, such as depression, schizophrenia, neurodegenerative diseases, and more. TMS can be used as a method of enhancing the effect of pharmacotherapy as well as a regular treatment.
Aim of the study: The study's aim is to summarize the current state of knowledge on transcranial magnetic stimulation as a method of treatment in depression and various neuropsychiatric conditions.
Material and methods: The study is based on the literature available in scientific databases such as PubMed, using the following keywords: „transcranial magnetic stimulation”, „tms”, “depression” and “treatment-resistant depression”.
Results and conclusions: Transcranial magnetic stimulation is a non-invasive, painless and generally safe method of diagnosis and treatment of many neuropsychiatric diseases, such as depression, schizophrenia, obsessive-compulsive disorders, neurodegenerative diseases, tinnitus, addiction to psychoactive substances and many more. TMS is a well-documented, approved, and recommended treatment primarily for treatment-resistant depression due to its effectiveness, mild side effect profile and good tolerability. Recently there are more and more reports on the effectiveness of TMS in the diagnosis and treatment of other neuropsychiatric conditions, but further research and setting guidelines are needed, so is increasing the availability of the method for patients.
References
Antczak J, Rakowicz M. Przezczaszkowa stymulacja magnetyczna w praktyce klinicznej. Neurologia po Dyplomie 2013; 8 (6): 28-37.
Klomjai W, Katz R, Lackmy-Vallée A. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Annals of Physical and Rehabilitation Medicine, Volume 58, Issue 4, 2015, Pages 208-213, ISSN 1877-0657, https://doi.org/10.1016/j.rehab.2015.05.005.
Koutsomitros T, Evagorou O, Schuhmann T, Zamar A, Sack AT. Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression. https://doi.org/10.22365/jpsych.2021.054 / Psychiatriki 2021, 32:S90–S98.
Sonmez AI, Camsari DD, Nandakumar AL, Voort JLV, Kung S, Lewis CP, Croarkin PE. Accelerated TMS for Depression: A systematic review and meta-analysis. Psychiatry Res. 2019 Mar;273:770-781. doi: 10.1016/j.psychres.2018.12.041. Epub 2018 Dec 7. PMID: 31207865; PMCID: PMC6582998.
Cappon D, den Boer T, Jordan C, Yu W, Metzger E, Pascual-Leone A. Transcranial magnetic stimulation (TMS) for geriatric depression. Ageing Res Rev. 2022 Feb;74:101531. doi: 10.1016/j.arr.2021.101531. Epub 2021 Nov 25. PMID: 34839043; PMCID: PMC8996329.
Croarkin PE, Nakonezny PA, Deng ZD, Romanowicz M, Voort JLV, Camsari DD, Schak KM, Port JD, Lewis CP. High-frequency repetitive TMS for suicidal ideation in adolescents with depression. J Affect Disord. 2018 Oct 15;239:282-290. doi: 10.1016/j.jad.2018.06.048. Epub 2018 Jul 18. PMID: 30031247; PMCID: PMC6431788.
https://www.who.int/news-room/fact-sheets/detail/depression - WHO official website, depressive disorder current information
Rawji V, Latorre A, Sharma N, Rothwell JC, Rocchi L. On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases. Front Neurol. 2020 Nov 3;11:584664. doi: 10.3389/fneur.2020.584664. PMID: 33224098; PMCID: PMC7669623.
Goodman WK, Storch EA, Sheth SA. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry. 2021 Jan 1;178(1):17-29. doi: 10.1176/appi.ajp.2020.20111601. PMID: 33384007; PMCID: PMC8091795.
Vittala A, Murphy N, Maheshwari A, Krishnan V. Understanding Cortical Dysfunction in Schizophrenia With TMS/EEG. Front Neurosci. 2020 May 28;14:554. doi: 10.3389/fnins.2020.00554. PMID: 32547362; PMCID: PMC7270174.
di Hou M, Santoro V, Biondi A, Shergill SS, Premoli I. A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia. J Psychiatry Neurosci. 2021 Dec 21;46(6):E675-E701. doi: 10.1503/jpn.210006. PMID: 34933940; PMCID: PMC8695525.
Lorentzen R, Nguyen TD, McGirr A, Hieronymus F, Østergaard SD. The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. Schizophrenia (Heidelb). 2022 Apr 9;8(1):35. doi: 10.1038/s41537-022-00248-6. PMID: 35853882; PMCID: PMC9261093.
Rapinesi C, Kotzalidis GD, Ferracuti S, Sani G, Girardi P, Del Casale A. Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review. Curr Neuropharmacol. 2019;17(8):787-807. doi: 10.2174/1570159X17666190409142555. PMID: 30963971; PMCID: PMC7059162.
Pellegrini L, Garg K, Enara A, Gottlieb DS, Wellsted D, Albert U, Laws KR, Fineberg NA. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications. Comprehensive Psychiatry, Volume 118, 2022, 152339, ISSN 0010-440X, https://doi.org/10.1016/j.comppsych.2022.152339.
Kallioniemi E, Saari J, Ferreri F, Määttä S. TMS-EEG responses across the lifespan: Measurement, methods for characterisation and identified responses. Journal of Neuroscience Methods, Volume 366, 2022, 109430, ISSN 0165-0270, https://doi.org/10.1016/j.jneumeth.2021.109430.
Galal S, Ismail N, Niel G. A Systematic Review and Meta-analysis of Randomized Controlled Trials on the Effect of Transcranial Magnetic Stimulation on Tinnitus Management. Cent Asian J Glob Health. 2020 Mar 31;9(1):e356. doi: 10.5195/cajgh.2020.356. PMID: 35866094; PMCID: PMC9295851.
Roth Y, Zibman S, Pell GS, Zangen A, Tendler A. Revisiting the Rotational Field TMS Method for Neurostimulation. J Clin Med. 2023 Jan 27;12(3):983. doi: 10.3390/jcm12030983. PMID: 36769630; PMCID: PMC9917411.
Caipa A, Alomar M, Bashir S. TMS as tool to investigate the effect of pharmacological medications on cortical plasticity. Eur Rev Med Pharmacol Sci 2018; 22 (3): 844-852. DOI: 10.26355/eurrev_201802_14321.
Denton AJ, Finberg A, Ashman PE, Bencie NB, Scaglione T, Kuzbyt B, Telischi FF, Mittal R, Eshraghi AA. Implications of Transcranial Magnetic Stimulation as a Treatment Modality for Tinnitus. J Clin Med. 2021 Nov 20;10(22):5422. doi: 10.3390/jcm10225422. PMID: 34830704; PMCID: PMC8622674.
Turco CV, Arsalan SO, Nelson AJ. The Influence of Recreational Substance Use in TMS Research. Brain Sci. 2020 Oct 18;10(10):751. doi: 10.3390/brainsci10100751. PMID: 33080965; PMCID: PMC7603156.
Wieczorek T, Kobyłko A, Stramecki F, et al. Transcranial magnetic stimulation (TMS) in treatment of psychiatric disorders – review of current studies. Psychiatria Polska. 2021;55(3):565-583. doi:10.12740/PP/OnlineFirst/115556.
Pandarakalam JP. Challenges of treatment-resistant depression. Psychiatria Danubina, 2018; Vol. 30, No. 3, pp 273-284 https://doi.org/10.24869/psyd.2018.273
Poleszczyk A. Postępowanie w depresji lekoopornej. Neurologia po Dyplomie 2016; 04. https://podyplomie.pl/neurologia/22329,postepowanie-w-depresji-lekoopornej.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ilona Kowalczyk, Bartłomiej Zielonka, Cezary Stawikowski, Paulina Krawiec, Karolina Madej, Marta Wolanin, Izabela Wolanin, Bartłomiej Stachyra, Aleksandra Osińska, Barbara Dengler
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 464
Number of citations: 0
